Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    PARKINSON DISEASE 8, AUTOSOMAL DOMINANT
Show Display Options
Rank Status Study
1 Completed Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
Condition: Parkinson's Disease
Intervention: Drug: 18F-DTBZ

Study has passed its completion date and status has not been verified in more than two years.